or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
    Stephenson Oklahoma Cancer Center
    Oklahoma City, Oklahoma 73104
    Infusion Reactions
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Peggy and Charles Stephenson Cancer Center
    Oklahoma City, Oklahoma 73104
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
    Universtiy of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cervical Cancer, Endometrial Cancer, Gastrointestinal Complications, Perioperative/Postoperative Complications, Radiation Toxicity, Urinary Complications, Urinary Tract Toxicity
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage IIIB Cervical Cancer, Stage IVA Cervical Cancer
    TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Non-HPV Locally Advanced Head and Neck Cancer
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Hemophilia A
    Proton Radiation for Stage III Breast Cancer
    ProCure Proton Therapy Center
    Oklahoma City, Oklahoma 73142
    Breast Cancer, Breast Neoplasm, Breast Tumor, Cancer of the Breast
    Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
    Oklahoma Foundation for Digestive Research
    Oklahoma City, Oklahoma 73104
    Ulcerative Colitis
    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
    ProCure Proton Therapy Center
    Oklahoma City, Oklahoma 73142
    Breast Cancer, Breast Neoplasm, Breast Tumor, Cancer of the Breast
    Registry and Fluid Banking of Pancreatic Cystic Lesions
    Endoscopy Centrer at OU Medical Center
    Oklahoma City, Oklahoma 73104
    Pancreatic Cysts
    Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer
    Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Pancreatic Cancer, Pancreatic Carcinoma Non-resectable, Locally Advanced Malignant Neoplasm
    RSSearch Registry-Long Term Study of Use of SRS/SBRT to Treat Tumors and Other Functional Diseases
    St Anthony's
    Oklahoma City, Oklahoma 73102
    Neoplasms, Arteriovenous Malformations, Trigeminal Neuralgia
    Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
    Stephensen Cancer Center
    Oklahoma City, Oklahoma 73104
    Pancreatic Cancer
    Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer, Ovarian Cancer
    Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Leukemia, Liver Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Psychosocial Effects of Cancer and Its Treatment, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
    Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Sarcoma
    Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer, Vaginal Cancer
    Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    St. Anthony Hospital
    Oklahoma City, Oklahoma 73101
    Lung Cancer
    Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lung Cancer
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    Children's Hospital of Oklahoma
    Oklahoma City, Oklahoma 73104
    Kidney Cancer
    Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Breast Cancer
    SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Leukemia, Neutropenia, Thrombocytopenia
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    St. Anthony Hospital
    Oklahoma City, Oklahoma 73101
    Metastatic Cancer
    Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Head and Neck Cancer
    Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Leukemia
    S9630, Medroxyprogesterone in Treating Women With Breast Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Breast Cancer, Endometrial Cancer
    S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
    Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma 73104
    Adrenocortical Carcinoma
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lung Cancer
    Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Children's Hospital at Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Sarcoma
    S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Pancreatic Cancer
    Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Sarcoma
    Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Cardiac Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific